KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Current Leases (2020 - 2025)

Historic Current Leases for Aurinia Pharmaceuticals (AUPH) over the last 5 years, with Q3 2025 value amounting to $16.3 million.

  • Aurinia Pharmaceuticals' Current Leases rose 925.84% to $16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.3 million, marking a year-over-year increase of 925.84%. This contributed to the annual value of $14.0 million for FY2024, which is 385.38% down from last year.
  • Latest data reveals that Aurinia Pharmaceuticals reported Current Leases of $16.3 million as of Q3 2025, which was up 925.84% from $16.2 million recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Current Leases registered a high of $16.3 million during Q3 2025, and its lowest value of $918000.0 during Q3 2022.
  • Moreover, its 5-year median value for Current Leases was $13.3 million (2023), whereas its average is $8.1 million.
  • Its Current Leases has fluctuated over the past 5 years, first plummeted by 1737.17% in 2022, then skyrocketed by 146079.06% in 2023.
  • Aurinia Pharmaceuticals' Current Leases (Quarter) stood at $1.1 million in 2021, then fell by 11.61% to $936000.0 in 2022, then soared by 1460.79% to $14.6 million in 2023, then decreased by 3.85% to $14.0 million in 2024, then increased by 16.11% to $16.3 million in 2025.
  • Its Current Leases was $16.3 million in Q3 2025, compared to $16.2 million in Q2 2025 and $14.5 million in Q1 2025.